ATE184650T1 - Verfahren zur herstellung von spirolaxin und spirolaxinmethylether - Google Patents

Verfahren zur herstellung von spirolaxin und spirolaxinmethylether

Info

Publication number
ATE184650T1
ATE184650T1 AT95911486T AT95911486T ATE184650T1 AT E184650 T1 ATE184650 T1 AT E184650T1 AT 95911486 T AT95911486 T AT 95911486T AT 95911486 T AT95911486 T AT 95911486T AT E184650 T1 ATE184650 T1 AT E184650T1
Authority
AT
Austria
Prior art keywords
spirolaxin
atcc
pct
methyl ether
producing
Prior art date
Application number
AT95911486T
Other languages
English (en)
Inventor
Mark A Guadliana
Liang H Huang
Takushi Kaneko
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE184650T1 publication Critical patent/ATE184650T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
AT95911486T 1995-03-30 1995-03-30 Verfahren zur herstellung von spirolaxin und spirolaxinmethylether ATE184650T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000217 WO1996030538A1 (en) 1995-03-30 1995-03-30 Process for preparing spirolaxine and spirolaxine methyl ether

Publications (1)

Publication Number Publication Date
ATE184650T1 true ATE184650T1 (de) 1999-10-15

Family

ID=11004322

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95911486T ATE184650T1 (de) 1995-03-30 1995-03-30 Verfahren zur herstellung von spirolaxin und spirolaxinmethylether

Country Status (12)

Country Link
US (1) US6074855A (de)
EP (1) EP0817863B1 (de)
JP (1) JP3078845B2 (de)
AT (1) ATE184650T1 (de)
AU (1) AU691738B2 (de)
CA (1) CA2214871C (de)
DE (1) DE69512279T2 (de)
DK (1) DK0817863T3 (de)
ES (1) ES2135710T3 (de)
FI (1) FI973831A0 (de)
GR (1) GR3031213T3 (de)
WO (1) WO1996030538A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2867384B1 (fr) * 2004-03-15 2008-10-17 Lvmh Rech Compositions cosmetiques et dermatologiques a activite depigmentante

Also Published As

Publication number Publication date
FI973831A (fi) 1997-09-29
EP0817863B1 (de) 1999-09-15
DE69512279D1 (de) 1999-10-21
JPH10509051A (ja) 1998-09-08
WO1996030538A1 (en) 1996-10-03
AU5040596A (en) 1996-10-10
US6074855A (en) 2000-06-13
CA2214871C (en) 2002-02-12
AU691738B2 (en) 1998-05-21
JP3078845B2 (ja) 2000-08-21
ES2135710T3 (es) 1999-11-01
FI973831A0 (fi) 1997-09-29
DE69512279T2 (de) 1999-12-30
CA2214871A1 (en) 1996-10-03
GR3031213T3 (en) 1999-12-31
DK0817863T3 (da) 1999-12-20
EP0817863A1 (de) 1998-01-14

Similar Documents

Publication Publication Date Title
NO2015027I2 (no) Mepolizumab
ATE227346T1 (de) Verfahren zur spezifischen kopplung einer schutzgruppe an das 5'-ende eines mrna-fragmentes und die herstellung von mrna und vollständiger cdna
DE69522436D1 (de) Verfahren zur herstellung von äthylalkohol
DE59606782D1 (de) Fachwerk und gefacheelement und verfarhren zur herstellung eines gefacheelements
ATE224719T1 (de) Phosphatidsäure enthaltende zusammensetzungen
DE69513847D1 (de) Verfahren zur herstellung von substituierten 3-aminobenzonitrilen
DE3888523D1 (de) Verfahren zur herstellung von 4,4'-dibromdiphenylether.
ATE224149T1 (de) Verfahren zur herstellung von stabilen trüben extrakten
ATE184650T1 (de) Verfahren zur herstellung von spirolaxin und spirolaxinmethylether
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE59510636D1 (de) Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
ATE215552T1 (de) Verfahren zur herstellung von ivermectin
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
DE69515053D1 (de) Verfahren zur herstellung von furosemide
ATE175668T1 (de) Verfahren zur herstellung von 8-g(a),12-oxido- 13,14,15,16-tetranorlabdan
DE3767843D1 (de) Verfahren zur herstellung von 2-brom-1',2'-dichloroperfluordiethylether.
MX9707452A (es) Procedimiento para preparar espirolaxina y eter metilico de espirolaxina.
DE69514115D1 (de) Verfahren zur herstellung von levobupivacain und analogue aus l-lysin
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
ATE250078T1 (de) Verfahren zur herstellung von 4,4-dimethyl-5 alpha-cholesta-8,14,24-trien-3 beta-ol und zwischenprodukte im verfahren (i)
ATE247618T1 (de) Verfahren zur herstellung von 1,4-diaryl-2-fluor- 1,3-butadien- und 1,4-diaryl-2-fluor-2- butenverbindungen
PL322847A1 (en) Condensed b-carbolins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee